PLX Operating Income Growth
Protalix Biotherapeutics Inc · Operating Income Growth
PLX Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported298.63%period ending
PLX Quarterly Operating Income YoY % (-1900.00% → 298.63%)
Year-over-year change
High-resolution chart · PNG
PLX operating income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Income Growth |
|---|---|
| 298.6348% | |
| 610.1569% | |
| -164.6137% | |
| -46.6049% | |
| 148.2901% | |
| 14.6417% | |
| 228.3882% | |
| 311.4997% | |
| -111.8848% | |
| -97.4786% | |
| -125.0501% | |
| 39.616% | |
| 469.6778% | |
| -31.4973% | |
| 56.2741% | |
| -65.7825% | |
| 39.7338% | |
| 49.5277% | |
| -300.9863% | |
| 26.9946% | |
| -309.1964% | |
| -178.9474% | |
| 29.0455% | |
| -67.228% | |
| 61.6373% | |
| 184.803% | |
| 159.9129% | |
| 58.7276% | |
| 13.4193% | |
| -7.4354% | |
| 67.8403% | |
| 51.8223% | |
| 37.5845% | |
| 19.0731% | |
| -30.9404% | |
| -16.802% | |
| -8.8007% | |
| 19.0615% | |
| -13.2468% | |
| -32.9068% | |
| -77.8474% | |
| -46.0624% | |
| -8.7417% | |
| 19.4265% | |
| -2.5151% | |
| 16.7594% | |
| 30.2227% | |
| -9.9734% | |
| 20.9893% | |
| -46.0375% | |
| 0.1869% | |
| -1.5288% | |
| -171.6632% | |
| 26.9744% | |
| -14.7776% | |
| 36.5804% | |
| 162.806% | |
| -20.3851% | |
| -0.113% | |
| -207.8301% | |
| -50.9064% | |
| 37.9557% | |
| 41.0723% | |
| 52.8945% | |
| -72.8248% | |
| -61.2711% | |
| -138.6364% | |
| 10.003% | |
| -19.9061% | |
| 19.6072% | |
| -4.5183% | |
| -4.4628% | |
| 47.5308% | |
| -65.644% | |
| 37.3308% | |
| -153.4884% | |
| -166.7905% | |
| -130.9713% | |
| -36,703.1876% | |
| -6,969.8063% | |
| -17,014.2089% | |
| -14,969.502% | |
| 18.7062% | |
| 18.2239% | |
| 65.8727% | |
| 63.4045% | |
| 34.281% | |
| -32.9033% | |
| -93.495% | |
| 14.0864% | |
| 6.9995% | |
| 7.6678% | |
| 16.038% | |
| 14.9472% | |
| 66.3782% | |
| 39.052% | |
| 43.3102% | |
| 61.6764% | |
| 28.98% | |
| -276.7853% |